Physician profile
Jason Jones
NPI 1407115397
$694.06
in general payments reported to CMS, 2019-2025
10 companies · $20.58 in 2025
The $20.58 reported for 2025 was less than what a typical Anatomic Pathology & Clinical Pathology provider received nationally (typical 2025 total: $50.59).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.81 · 2020: $130 · 2021: $272 · 2022: $184 · 2023: $30.48 · 2024: $15.98 · 2025: $20.58.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $67.04.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $67.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $390.51 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.90 | 2021-2022 | |
| Regeneron Healthcare Solutions, INC. | $55.57 | 2022-2025 | Dupixent |
| Pharmacosmos Therapeutics INC. | $49.11 | 2021 | |
| Intercept Pharmaceuticals, INC. | $31.00 | 2022-2023 | Ocaliva |
| Ironwood Pharmaceuticals, INC | $15.98 | 2024 | |
| Nestle Healthcare Nutrition INC. | $14.93 | 2022 | |
| Merck Sharp & Dohme LLC | $12.90 | 2023 | Dificid |
| Ardelyx, INC. | $12.31 | 2022 | |
| Shire North American Group INC | $11.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.